Phase 2 of the Wuthering Waves 2.3 update officially kicked off on May 22, 2025, and it features several Resonators. Ciaccona is the newest entry to the playable roster – she hails from the Aero ...

Prayagraj: The Uttar Pradesh Public Service Commission(UPPSC) is revolutionising the recruitment process for assistant professors in 171 govt colleges across the state. Ditching the traditional ...

Mumbai: Mumbai is poised to open another leg of its first underground Metro, with Phase 2 of Metro Line 3 — the Aqua Line — set to become operational from Saturday, May 10. Chief Minister ...

If you stay consistent, the results will come.' INSTRUCTIONS: Start with Phase 1 and complete Workouts 1, 2, and 3 on nonconsecutive days each week. Repeat the Phase 1 workouts until you can ...

Dive into Sprunki MSI Canon Phase 3, where new characters and immersive soundscapes deepen the narrative. Experience a thrilling evolution of dark themes. Sprunki MSI Phase 3 represents a thrilling ...

In order to expand the application of the PMSM in the field of high-power traction, a robust predictive torque control (R-PTC) strategy for the N-segment three-phase PMSM (N*3-phase PMSM) is proposed ...

The Phase 2A (Aqua Line) of Mumbai Metro Line 3 will be open to the public on Saturday, May 10. The line will run from Bandra Kurla Complex (BKC) to Worli (Acharya Atre Chowk). The 9.77-kilometer ...

Phase 2A, the second operational leg of Mumbai's first totally underground metro corridor, the Aqua Line (Metro Line 3), has opened, offering a quick and direct underground connection between the ...

The Phase 2A of Mumbai's much-awaited underground Metro Line-3 was inaugurated on Friday (May 9) by Maharashtra Chief Minister Devendra Fadnavis, connecting Bandra-Kurla Complex (BKC) to Acharya Atre ...

Abstract: In this article, a novel predictive torque and stator flux control (PTSF) method is proposed for N-segment three-phase permanent magnet synchronous motor (N*3-phase PMSM), which can ...

This study is the first randomized, double-blind, controlled Phase 3 clinical study evaluating biologics switching in psoriasis patients with prior inadequate response to anti-IL-17 antibody.

With respect to this article, I rated the company a "Strong Buy" and noted that it was gearing up to release data from its phase 3 HARMONi study using its drug ivonescimab in combination with ...